Replies to post #332619 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

I think that the FDA guidance is the determining factor whether that trials can be considered pivotal or not.

So far Anavex has shared very little of what conversations and guidance it is having with the FDA.

[TempePhil]

Ripper, good news!
Check the latest Corp presentation.
Both the upcoming FragileX and the Undisclosed disease trials are both expected to be PIVOTAL P2/3 trials, and starting yet this year!
Also, I imagine they will fill quickly, as Dr.Hagerman will certainly be behind one (think the ACTUAL proverbial rolodex), and probably both.

Thanks for reminding everyone about that.

It looks like a2-73 trials may all be pivotal P2/3 trials going forward.
Nice!